Japanese pharma Takeda launches innovation centre, eyes to onboard AI-driven talent

Share via:


Japanese pharmaceutical company Takeda inaugurated its first Innovation Capability Centre (ICC) in Bengaluru, marking its debut in Asia. The ICC aims to employ 750 professionals, including software engineers, data scientists, and cybersecurity experts, with a strong focus on AI-driven talent, the company said on Wednesday.

Speaking to ET on the sidelines of the inauguration, Takeda’s chief data and technology officer, Gabriele Ricci, said the company chose Bengaluru for its robust talent pool in data, digital, and technology, as well as its unique ecosystem of academia, startups, and tech partners.

The CTO said it views AI as a key enabler in drug discovery, clinical trials, manufacturing, and patient care. “We are living in amazing times with the intersection of science and technology. Emerging technologies like AI, generative AI, and robotics offer unique opportunities to create solutions that can impact healthcare systems worldwide,” Ricci said.

Ricci added that the Bengaluru facility will focus on developing products such as a plasma-derived therapies donor management system and a global platform for healthcare professional (HCP) data. “The Indian team will also develop scalable, multi-language tools and other digital products to enhance patient support and care experiences,” he said.

Over the next few years, Takeda plans to expand its focus on therapeutic areas such as inflammation, oncology, and rare conditions, with investments in plasma-derived therapies and vaccines, Ricci said during the ICC launch.


The company is currently undergoing clinical trials and regulatory approvals to launch its Dengue vaccine– Qdenga, in Indian markets by 2026. Takeda plans to leverage local manufacturing under the ‘Make in India’ initiative to deliver the vaccine.

Discover the stories of your interest


The pharma company has been improving its high-value late stage pipeline with plans to file eight regulatory filings between 2025-2029 and make revenue of $10 billion to $20 billion, as per Takeda’s official website.



Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

admin
admin
Hi! This is Admin.

Popular

More Like this

Japanese pharma Takeda launches innovation centre, eyes to onboard AI-driven talent


Japanese pharmaceutical company Takeda inaugurated its first Innovation Capability Centre (ICC) in Bengaluru, marking its debut in Asia. The ICC aims to employ 750 professionals, including software engineers, data scientists, and cybersecurity experts, with a strong focus on AI-driven talent, the company said on Wednesday.

Speaking to ET on the sidelines of the inauguration, Takeda’s chief data and technology officer, Gabriele Ricci, said the company chose Bengaluru for its robust talent pool in data, digital, and technology, as well as its unique ecosystem of academia, startups, and tech partners.

The CTO said it views AI as a key enabler in drug discovery, clinical trials, manufacturing, and patient care. “We are living in amazing times with the intersection of science and technology. Emerging technologies like AI, generative AI, and robotics offer unique opportunities to create solutions that can impact healthcare systems worldwide,” Ricci said.

Ricci added that the Bengaluru facility will focus on developing products such as a plasma-derived therapies donor management system and a global platform for healthcare professional (HCP) data. “The Indian team will also develop scalable, multi-language tools and other digital products to enhance patient support and care experiences,” he said.

Over the next few years, Takeda plans to expand its focus on therapeutic areas such as inflammation, oncology, and rare conditions, with investments in plasma-derived therapies and vaccines, Ricci said during the ICC launch.


The company is currently undergoing clinical trials and regulatory approvals to launch its Dengue vaccine– Qdenga, in Indian markets by 2026. Takeda plans to leverage local manufacturing under the ‘Make in India’ initiative to deliver the vaccine.

Discover the stories of your interest


The pharma company has been improving its high-value late stage pipeline with plans to file eight regulatory filings between 2025-2029 and make revenue of $10 billion to $20 billion, as per Takeda’s official website.



Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Website Upgradation is going on for any glitch kindly connect at office@startupnews.fyi

admin
admin
Hi! This is Admin.

More like this

Bitcoin breaches 100k mark on Trump’s crypto promise. What...

Bitcoin crossed USD101,000 amid after a brief decline...

Huawei takes Mate XT, world’s first trifold smartphone, global...

Huawei is taking its — and the world's...

Everything you need to know about laptops you can...

The goal, Patel says, is to continuously cycle...

Popular

Upcoming Events

Startup Information that matters. Get in your inbox Daily!